
Wave Life Sciences, Inc.: shareholders and insiders
Price
$2.72
November 19, 2026Market cap $523M
What Ploutos Investor adds for Wave Life Sciences
Part of Ploutos Investor, €9.99 a month
- The full history: 11 fiscal years, from 2015
- The estimated fair value, with its range and its certainty
- The full analysis, 18 a month
- More questions to the chat on its filings
- Excel with every year
- An email when it reports, changes its dividend or an officer buys
Sign in with a free account to see the last 5 fiscal years.
Insiders and their shares
Purchases and sales by officers and directors from Nov 20, 2025 to Oct 7, 2026, from their own Form 4 filings.
Bought on the market
$83M
2 people
Sold on the market
$16M
11 people
From Nov 20, 2025 to Nov 20, 2026, the days the chart shows. Change its range and the figures follow.
How the sales were made, as a share of their value
- Under a set plan98%
- The rest2%
By year
Insiders' open-market purchases (up) and sales (down), by value, since Nov 20, 2025, on a log scale: each gridline is ten times the last. From the SEC's quarterly data sets of Form 4 filings.
2026·bought $55M by 1 person·sold $1.0M by 8 people
- 2025: bought $28M by 1 person, sold $15M by 8 people
- 2026: bought $55M by 1 person, sold $1.0M by 8 people
- Oct 5, 2026Ra Capital Management, L.p.DirectorKind
- Oct 5, 2026Gregory L. VerdineDirectorKind
- Oct 5, 2026Aik Na TanDirectorKind
- Oct 5, 2026Ken TakanashiDirectorKind
- Oct 5, 2026Mark CorriganDirectorKind
- Oct 5, 2026Adrian RawcliffeDirectorKind
- Oct 5, 2026Heidi L WagnerDirectorKind
- Oct 5, 2026Christian O HenryDirectorKind
- Aug 12, 2026Adrian RawcliffeDirectorKind10b5-1
- Aug 11, 2026Heidi L WagnerDirectorKind10b5-1
- Aug 11, 2026Heidi L WagnerDirectorKind10b5-1
- Aug 11, 2026Ken TakanashiDirectorKind10b5-1
- Aug 11, 2026Aik Na TanDirectorKind10b5-1
- Mar 30, 2026Ra Capital Management, L.p.Kind
- Mar 27, 2026Ra Capital Management, L.p.Kind
- Mar 26, 2026Ra Capital Management, L.p.Kind
- Mar 26, 2026Ra Capital Management, L.p.Kind
- Feb 26, 2026Chris FrancisKind10b5-1
- Feb 26, 2026Chris FrancisKind10b5-1
- Feb 9, 2026Chandra VargeeseKind
- Feb 9, 2026Chris FrancisKind
- Feb 9, 2026Paul BolnoPresident and CEOKind
- Feb 9, 2026Kyle MoranChief Financial OfficerKind
- Jan 2, 2026Chris FrancisKind10b5-1
- Jan 2, 2026Chris FrancisKind10b5-1
| Date | Person | Kind | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Oct 5, 2026 | Ra Capital Management, L.p.Director | 10.7K | – | – | Form 4 | |
| Oct 5, 2026 | Gregory L. VerdineDirector | 10.7K | – | – | Form 4 | |
| Oct 5, 2026 | Aik Na TanDirector | 10.7K | – | – | Form 4 | |
| Oct 5, 2026 | Ken TakanashiDirector | 10.7K | – | – | Form 4 | |
| Oct 5, 2026 | Mark CorriganDirector | 10.7K | – | – | Form 4 | |
| Oct 5, 2026 | Adrian RawcliffeDirector | 10.7K | – | – | Form 4 | |
| Oct 5, 2026 | Heidi L WagnerDirector | 10.7K | – | – | Form 4 | |
| Oct 5, 2026 | Christian O HenryDirector | 10.7K | – | – | Form 4 | |
| Aug 12, 2026 | Adrian RawcliffeDirector | 10b5-1 | 12.7K | $5.29 | $67.2K | Form 4 |
| Aug 11, 2026 | Heidi L WagnerDirector | 10b5-1 | 7,000 | $5.97 | $41.8K | Form 4 |
| Aug 11, 2026 | Heidi L WagnerDirector | 10b5-1 | 7,000 | $6.01 | $42.1K | Form 4 |
| Aug 11, 2026 | Ken TakanashiDirector | 10b5-1 | 3,864 | $6.01 | $23.2K | Form 4 |
| Aug 11, 2026 | Aik Na TanDirector | 10b5-1 | 432 | $6.01 | $2.6K | Form 4 |
| Mar 30, 2026 | Ra Capital Management, L.p. | 971.1K | $6.50 | $6.3M | Form 4 | |
| Mar 27, 2026 | Ra Capital Management, L.p. | 2.50M | $6.43 | $16M | Form 4 | |
| Mar 26, 2026 | Ra Capital Management, L.p. | 4.95M | $6.06 | $30M | Form 4 | |
| Mar 26, 2026 | Ra Capital Management, L.p. | 351.2K | $6.38 | $2.2M | Form 4 | |
| Feb 26, 2026 | Chris Francis | 10b5-1 | 15.3K | $15.00 | $229.4K | Form 4 |
| Feb 26, 2026 | Chris Francis | 10b5-1 | 17.9K | $15.09 | $270.1K | Form 4 |
| Feb 9, 2026 | Chandra Vargeese | 3,228 | $13.45 | $43.4K | Form 4 | |
| Feb 9, 2026 | Chris Francis | 1,883 | $13.45 | $25.3K | Form 4 | |
| Feb 9, 2026 | Paul BolnoPresident and CEO | 10.5K | $13.45 | $141.0K | Form 4 | |
| Feb 9, 2026 | Kyle MoranChief Financial Officer | 3,588 | $13.45 | $48.3K | Form 4 | |
| Jan 2, 2026 | Chris Francis | 10b5-1 | 8,080 | $15.92 | $128.6K | Form 4 |
| Jan 2, 2026 | Chris Francis | 10b5-1 | 1,295 | $16.70 | $21.6K | Form 4 |
From the Form 4s insiders file with the SEC within two business days of each trade. Before Aug 13, 2026 the table lists open-market purchases and sales only (no grants, option exercises or tax withholding), from the SEC's quarterly data sets. The 10b5-1 mark comes from the form's own box (since April 2023) or from a footnote of the filing that names the plan, where there is one.
Insiders and their shares
Every buy and sale by WVE's officers and directors from 2015 up to November 19, 2025, 11 more calendar years
Part of Ploutos Investor, €9.99 a month
Sign in with a free account to see the last 3 years.
and 6 more, back to 2015
Major holders (over 5%)
Whoever comes to own more than 5% of a class of shares reports it to the SEC on Schedule 13D or 13G. Here is each holder's latest filing.
- RA Capital Management, L.P.with 3 more personsShare of class17.1%
- RA Capital Management, L.P.with 3 more personsShare of class16.8%
- BlackRock, Inc.Share of class6.80%
- Maverick Capital, Ltd.with 2 more persons$0 Par Value Ordinary SharesShare of class5.40%
| Holder | Kind of stake | Share of class | Shares | Filed | Filing |
|---|---|---|---|---|---|
| RA Capital Management, L.P.with 3 more persons | 17.1% | 34.23M | Apr 17, 20262 filings since Mar 30, 2026 | 13D/A | |
| RA Capital Management, L.P.with 3 more persons | 16.8% | 34.31M | Aug 11, 20263 filings since Nov 13, 2025 | 13D/A | |
| BlackRock, Inc. | 6.80% | 13.36M | Oct 27, 20262 filings since Feb 5, 2025 | 13G | |
| Maverick Capital, Ltd.with 2 more persons$0 Par Value Ordinary Shares | 5.40% | 8.26M | Feb 14, 2025 | 13G/A |
What the holders on a 13D state as their purpose
From Item 4 of the filing, in the holder's own words. It is the intention the holder states, not something that happened.
RA Capital Management, L.P.17.1%From the filing of Apr 17, 2026
Item 4 of the Statement is hereby amended and supplemented as follows: On April 15, 2026, the Issuer into an Implementation Agreement, dated as of April 15, 2026 (the "Implementation Agreement"), with a newly established Delaware corporation, Wave Life Sciences, Inc. ("Wave-Delaware"). The Implementation Agreement provides for a statutory procedure known as a Scheme of Arrangement (the "Scheme of Arrangement") to be implemented by the Issuer and Wave-Delaware under Singapore law, subject to approval of the High Court of the Republic of Singapore (the "Singapore Court"). Pursuant to the Scheme of Arrangement, all issued ordinary shares in the capital of the Issuer as of immediately prior to…
From the filing of Apr 17, 2026RA Capital Management, L.P.16.8%From the filing of Aug 11, 2026
Item 4 of the Statement is hereby amended and supplemented as follows: On August 7, 2026, as part of the Redomiciliation, Wave-Delaware, became the ultimate parent company of the Wave Life Sciences group of companies. Pursuant to the Scheme of Arrangement, all issued ordinary shares in the capital of Wave Life Sciences Ltd. ("Wave-Singapore") as of immediately prior to the effective time of the Scheme of Arrangement were exchanged on a one-for-one basis for newly issued shares of common stock, par value $0.001 per share, of Wave-Delaware, and Wave-Singapore became a wholly owned subsidiary of Wave-Delaware.
From the filing of Aug 11, 2026
Fell to 5% or less (3)
Holders whose latest filing says they hold 5% or less. After it they need not file again, so what they hold today is not known.
From the Schedule 13D and 13G filed with the SEC since Dec 18, 2024, when they became structured data. A holder who has filed nothing since then is not shown here. A 13D is updated within two business days of any material change, a 13G up to 45 days after the quarter of the change, so the shares are those of the filing. The large managers also appear in the 13Fs.
Well-known managers
Which of the about 30 investment managers we track held the shares at the quarter end, and what they changed from the quarter before.
- Duquesne (Druckenmiller)In the quarter
- Point72 (Cohen)In the quarter
- D.E. ShawIn the quarter
- Renaissance TechnologiesIn the quarter
- Citadel Advisors (Griffin)In the quarter
- Millennium Mgmt (Englander)In the quarter
- AQR CapitalIn the quarter
| Manager | Shares | In the quarter | Value | % of their portfolio |
|---|---|---|---|---|
| Duquesne (Druckenmiller) | 173.0K | $600.0K | 0.02% | |
| Point72 (Cohen) | 1.14M | $4.2M | 0.01% | |
| D.E. Shaw | 2.54M | $9.4M | 0.01% | |
| Renaissance Technologies | 2.19M | $8.1M | 0.01% | |
| Citadel Advisors (Griffin) | 1.53M | $5.7M | 0.00% | |
| Millennium Mgmt (Englander) | 809.5K | $3.0M | 0.00% | |
| AQR Capital | 215.8K | $800.0K | 0.00% |
From the 13Fs managers file with the SEC up to 45 days after each quarter end. They show only long positions on that day, not short sales or what has changed since. No recent 13F: Pershing Square (Ackman), Scion (Burry).
Short interest
How many of the company's shares have been sold borrowed and not yet bought back, twice a month.
On Oct 15, 2026, 11.0% of its shares outstanding were held short, +14.1% since the report before.
- Shares held short
- 21.17M
- 11.0%
- Since the report before18.56M on Sep 30, 2026
- +14.1%
- 6.5
- 3.24M
- More days to cover thanof 4,578 US-listed companies with enough volume
- 75%
- Report date
- Oct 15, 2026
- Shares held short
- Oct 31, 2023: Shares held short 3.59M
- Nov 15, 2023: Shares held short 3.48M
- Nov 30, 2023: Shares held short 3.26M
- Dec 15, 2023: Shares held short 3.20M
- Dec 29, 2023: Shares held short 3.18M
- Jan 12, 2024: Shares held short 3.22M
- Jan 31, 2024: Shares held short 2.96M
- Feb 15, 2024: Shares held short 2.51M
- Feb 29, 2024: Shares held short 2.98M
- Mar 15, 2024: Shares held short 3.00M
- Mar 28, 2024: Shares held short 3.59M
- Apr 15, 2024: Shares held short 3.15M
- Apr 30, 2024: Shares held short 2.78M
- May 15, 2024: Shares held short 2.77M
- May 31, 2024: Shares held short 2.53M
- Jun 14, 2024: Shares held short 3.12M
- Jun 28, 2024: Shares held short 4.80M
- Jul 15, 2024: Shares held short 3.88M
- Jul 31, 2024: Shares held short 3.60M
- Aug 15, 2024: Shares held short 3.35M
- Aug 30, 2024: Shares held short 3.38M
- Sep 13, 2024: Shares held short 3.53M
- Sep 30, 2024: Shares held short 5.59M
- Oct 15, 2024: Shares held short 4.89M
- Oct 31, 2024: Shares held short 6.82M
- Nov 15, 2024: Shares held short 6.45M
- Nov 29, 2024: Shares held short 6.93M
- Dec 13, 2024: Shares held short 7.05M
- Dec 31, 2024: Shares held short 8.21M
- Jan 15, 2025: Shares held short 8.62M
- Jan 31, 2025: Shares held short 9.40M
- Feb 14, 2025: Shares held short 9.54M
- Feb 28, 2025: Shares held short 9.16M
- Mar 14, 2025: Shares held short 8.34M
- Mar 31, 2025: Shares held short 9.94M
- Apr 15, 2025: Shares held short 11.67M
- Apr 30, 2025: Shares held short 13.24M
- May 15, 2025: Shares held short 15.45M
- May 30, 2025: Shares held short 15.03M
- Jun 13, 2025: Shares held short 14.88M
- Jun 30, 2025: Shares held short 15.80M
- Jul 15, 2025: Shares held short 16.41M
- Jul 31, 2025: Shares held short 16.08M
- Aug 15, 2025: Shares held short 16.75M
- Aug 29, 2025: Shares held short 17.32M
- Sep 15, 2025: Shares held short 18.04M
- Sep 30, 2025: Shares held short 15.85M
- Oct 15, 2025: Shares held short 13.14M
- Oct 31, 2025: Shares held short 13.37M
- Nov 14, 2025: Shares held short 15.41M
- Nov 28, 2025: Shares held short 16.03M
- Dec 15, 2025: Shares held short 14.69M
- Dec 31, 2025: Shares held short 14.69M
- Jan 15, 2026: Shares held short 15.19M
- Jan 30, 2026: Shares held short 15.18M
- Feb 13, 2026: Shares held short 15.25M
- Feb 27, 2026: Shares held short 13.65M
- Mar 13, 2026: Shares held short 13.41M
- Mar 31, 2026: Shares held short 13.21M
- Apr 15, 2026: Shares held short 13.35M
- Apr 30, 2026: Shares held short 16.72M
- May 15, 2026: Shares held short 17.77M
- May 29, 2026: Shares held short 18.53M
- Jun 15, 2026: Shares held short 18.15M
- Jun 30, 2026: Shares held short 20.90M
- Jul 15, 2026: Shares held short 16.85M
- Jul 31, 2026: Shares held short 16.40M
- Aug 14, 2026: Shares held short 16.20M
- Aug 31, 2026: Shares held short 16.28M
- Sep 15, 2026: Shares held short 17.64M
- Sep 30, 2026: Shares held short 18.56M
- Oct 15, 2026: Shares held short 21.17M
As brokers report them to the regulator twice a month, mid-month and at month end, published about eight business days later. A short position is shares sold borrowed and not yet bought back. The share count is the one the company's market value is figured on, from its filings. Days to cover is the shares held short over the average daily volume of the weeks between two reports.
Short sales in daily trading46.8% of the shares in the last 14 sessions' reported trades were short sales.
In the last 14 sessions, 46.8% of the shares in the reported trades were short sales, against 43.5% in the 14 before.
- Last 14 sessionsNov 2, 2026 – Nov 19, 2026
- 46.8%
- The 14 beforeOct 13, 2026 – Oct 30, 2026
- 43.5%
- Change
- +3.3 pts
- Short sales a dayon average, of 1.05M shares
- 491.7K
- More than atof 3,666 US-listed companies, same days
- 37%
- Median of alleight in ten from 34.5% to 63.8%
- 50.4%
- Short sales
- Oct 13, 2026: Short sales 46.2%
- Oct 14, 2026: Short sales 38.9%
- Oct 15, 2026: Short sales 37.9%
- Oct 16, 2026: Short sales 46.7%
- Oct 19, 2026: Short sales 38.9%
- Oct 20, 2026: Short sales 50.4%
- Oct 21, 2026: Short sales 52.1%
- Oct 22, 2026: Short sales 39.4%
- Oct 23, 2026: Short sales 46%
- Oct 26, 2026: Short sales 53.1%
- Oct 27, 2026: Short sales 37.9%
- Oct 28, 2026: Short sales 34.4%
- Oct 29, 2026: Short sales 41.6%
- Oct 30, 2026: Short sales 48.6%
- Nov 2, 2026: Short sales 42.3%
- Nov 3, 2026: Short sales 42.5%
- Nov 4, 2026: Short sales 43.2%
- Nov 5, 2026: Short sales 40.1%
- Nov 6, 2026: Short sales 44.5%
- Nov 9, 2026: Short sales 41.6%
- Nov 10, 2026: Short sales 51%
- Nov 11, 2026: Short sales 44.3%
- Nov 12, 2026: Short sales 56.7%
- Nov 13, 2026: Short sales 51.2%
- Nov 16, 2026: Short sales 58.9%
- Nov 17, 2026: Short sales 50%
- Nov 18, 2026: Short sales 50.7%
- Nov 19, 2026: Short sales 49.7%
This is not the number of shares sold short today: it measures short sales within each day's trading, and only trades made off the exchanges. Much of it is market makers, who sell shares they do not have to fill buyers' orders and cover soon after, so for a heavily traded stock the share is often around half.
What the insiders hold
The shares each insider reports holding after their latest trade (Form 4), for those who traded on the market in the last three years.
- Ra Capital Management, L.p.Director,TenPercentOwnerDirectly8.81M
- Peter KolchinskyDirector,TenPercentOwnerDirectly–
- Ken TakanashiDirectorDirectly9.64M
- Gregory L. VerdineDirectorDirectly275.9K
- Heidi L WagnerDirectorDirectly55.6K
- Mark CorriganDirectorDirectly39.5K
- Aik Na TanDirectorDirectly35.7K
- Christian O HenryDirectorDirectly23.4K
- Adrian RawcliffeDirectorDirectly10.7K
| Person | Directly | Indirectly | After the trade of | Filing |
|---|---|---|---|---|
| Ra Capital Management, L.p.Director,TenPercentOwner | 8.81M | 18.20M | Oct 5, 2026 | Form 4 |
| Peter KolchinskyDirector,TenPercentOwner | – | 19.20M | Dec 11, 2023 | Form 4 |
| Ken TakanashiDirector | 9.64M | – | Oct 5, 2026 | Form 4 |
| Gregory L. VerdineDirector | 275.9K | – | Oct 5, 2026 | Form 4 |
| Heidi L WagnerDirector | 55.6K | – | Oct 5, 2026 | Form 4 |
| Mark CorriganDirector | 39.5K | – | Oct 5, 2026 | Form 4 |
| Aik Na TanDirector | 35.7K | – | Oct 5, 2026 | Form 4 |
| Christian O HenryDirector | 23.4K | – | Oct 5, 2026 | Form 4 |
| Adrian RawcliffeDirector | 10.7K | – | Oct 5, 2026 | Form 4 |
A lower bound: it counts only the 9 officers and directors with a market trade since Nov 21, 2023. Anyone who neither bought nor sold since is not here, whatever they hold. The share is against the share count on the latest 10-K's cover.
The ETFs that hold it
Which of the 345 US equity ETFs we track hold the stock, and at what weight, from the funds' N-PORT filings.
- IHEiShares U.S. Pharmaceuticals ETFWeight in the fund0.20%
- IWCiShares Micro-Cap ETFWeight in the fund0.18%
- IBBiShares Biotechnology ETFWeight in the fund0.08%
- IWNiShares Russell 2000 Value ETFWeight in the fund0.05%
- IWMiShares Russell 2000 ETFWeight in the fund0.03%
- VTWOVanguard Russell 2000 Index FundWeight in the fund0.02%
- SCHASchwab U.S. Small-Cap ETFWeight in the fund0.02%
- FESMFidelity Enhanced Small Cap Core ETFWeight in the fund0.01%
- DFASDimensional U.S. Small Cap ETFWeight in the fund0.01%
- VXFVanguard Extended Market Index FundWeight in the fund0.01%
18 of the 345 ETFs we track, not of every ETF on the market. The ten largest weights. Positions as each fund filed them in its latest N-PORT.
Institutional investors by quarter
Every manager that reports positions to the SEC (Form 13F), quarter by quarter: how many hold the stock, how many shares and dollars between them, and who entered, left, added or trimmed during the quarter.
- Managers
- Q3 2025: Managers 191
- Q4 2025: Managers 220
- Q1 2026: Managers 232
- Q2 2026: Managers 239
Institutional investors by quarter
The fund managers holding WVE, quarter by quarter, from Q4 2015 to Q2 2025, 39 more quarters
Part of Ploutos Investor, €9.99 a month
Sign in with a free account to see the last 12 quarters.
Q2 2026: 239 managers held 183M shares, worth $1.1B. During the quarter 51 opened a position, 44 closed one, 97 added and 53 trimmed.
The largest holders, Q2 2026
- Ra Capital ManagementIn the quarter
- BlackRockIn the quarter+36%
- GskIn the quarter
- Maverick CapitalIn the quarter+1.1%
- Driehaus Capital ManagementIn the quarter+0.2%
- Primecap ManagementIn the quarter+11%
- 683 Capital ManagementIn the quarter+1.0%
- FMRIn the quarter-5.2%
- State StreetIn the quarter+32%
- Readystate Asset ManagementIn the quarter
| Manager | Shares | In the quarter | Value |
|---|---|---|---|
| Ra Capital Management | 26.98M | $157M | |
| BlackRock | 19.20M | +36% | $112M |
| Gsk | 18.25M | $106M | |
| Maverick Capital | 10.28M | +1.1% | $60M |
| Driehaus Capital Management | 5.44M | +0.2% | $32M |
| Primecap Management | 5.35M | +11% | $31M |
| 683 Capital Management | 4.95M | +1.0% | $29M |
| FMR | 4.92M | -5.2% | $29M |
| State Street | 4.84M | +32% | $28M |
| Readystate Asset Management | 4.73M | $27M |
From the SEC's Form 13F data sets, Q3 2025 to Q2 2026: the long positions of every manager with more than $100 million under management, as filed up to 45 days after each quarter end. Short positions and options are not in them. Shares as reported each quarter, not adjusted for splits. The stock is matched by its CUSIP, through the SEC's fails-to-deliver files.
Pay against performance, the say-on-pay vote, buybacks by quarter and trading plans are read for S&P 500 companies only.
The full analysis
What do Wave Life Sciences's filings show?
Who buys and sells is one part of Wave Life Sciences's picture. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.
- A fair value range built from the filings
- Earnings quality, debt and red flags
- Insider and institutional moves
- The case for and the case against
Have WVE's insiders bought or sold?
From Aug 13, 2026 to Oct 7, 2026 Wave Life Sciences's insiders bought 0 and sold $135.1K of shares on the market. 100% of the sales were under set 10b5-1 plans.
Which well-known managers hold WVE?
7 of the managers we track held the shares on Sep 30, 2026. The largest position was D.E. Shaw's, worth $9.4M.
Is every insider transaction a purchase or a sale?
No. Many are part of their pay: share awards, option exercises and shares the company keeps for the tax. Only code P is a purchase with their own money, and code S a sale on the market.
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.